alvetex^® voted one of most technologically significant new research products by R&D magazine

27 / 06 / 2011

Sedgefield, UK. 23rd June 2011. Reinnervate, an innovative life sciences company driving the adoption of routine 3D cell culture, is delighted to announce that alvetex^®, its breakthrough 3D cell culture technology, is among the winners of the prestigious 49th Annual R&D 100 Awards.

Alvetex^® is a unique and proprietary cell culture scaffold that, for the first time, enables genuine 3D cell growth to be performed routinely and cost effectively in cell biology laboratories. Reinnervate launched its first product, the alvetex^® 12-well plate, in Europe at the end of November 2010 and introduced 6-well and 12-well inserts and petri dish formats at the end of March 2011. The Company intends to launch alvetex^® products in a range of other formats over the next 12 months, including 24, 48 and 96 well plates.

Alvetex^® was chosen by an independent judging panel and the editors of R&D Magazine to be among the 100 most technologically significant products introduced into the marketplace over the past year. The award will be presented to reinnervate at a special Gala Awards Banquet at the Renaissance Orlando Hotel at SeaWorld in Florida on 13th October 2011.

“The editors were impressed with the strong field of candidates for this year’s R&D 100 Awards. The number and quality of entrants far exceeded that of recent years,” said Rita Peters, editorial director of R&D Magazine.
Professor Stefan Przyborski, reinnervate’s Chief Scientific Officer and founder, commented: “We are extremely proud that alvetex^® has been selected as one of this year’s winners of the annual R&D 100 Awards. The team here at reinnervate and at Durham University have shown great dedication in bringing our game-changing alvetex^® technology to market and this award goes some way towards recognising their work. Here at reinnervate we continue to innovate and intend to launch further alvetex^® products onto the market over the next 12 months, including a 96-well plate suitable for high-throughput drug screening.”

Since 1963, the R&D 100 Awards have identified revolutionary technologies newly introduced to the market, many of which have become household names. Winners are picked from industry sectors as diverse as telecommunications, high-energy physics, software, manufacturing, and biotechnology and represent a cross-section of industry, academia, private research firms and government labs.

A full list of this year’s winning innovations is on the R&D 100 Awards website, www.rdmag.com.

For further information and images of award-winning alvetex^® products, please contact

Ashley Cooper, Chief Executive Officer
Barry Lynch, Marketing Manager
+44 (0)191 334 3988
info@reinnervate.com

Mark Swallow / Malcolm Robertson
Citigate Dewe Rogerson
+44 (0)207 638 9571
mark.swallow@citigatedr.co.uk

About reinnervate

Reinnervate is an innovative life sciences company dedicated to making routine 3D cell culture a reality for researchers in academia and in the pharmaceutical and related industries.

Reinnervate’s core technology is the award-winning alvetex^®, a unique and proprietary scaffold that enables routine 3D cell culture in the laboratory. Alvetex provides a nanoscale environment that supports genuine homogeneous 3D cell growth. Cells grown using alvetex^® form complex 3D tissue cultures which more closely mimic normal in-vivo cell growth and the formation of tissues in the body than conventional techniques. The use of alvetex^®-derived 3D cell cultures can provide researchers with greater insight into how cells behave in the body in response to external factors (such as drug candidates) than is currently possible with existing 2D or other emerging 3D cell culture technologies.

Reinnervate has generated significant data, which have been published extensively in peer-reviewed publications, exemplifying the use of alvetex in a large number of cell types and applications. Alvetex^® has been launched globally in several formats: a 12-well culture plate, 6-well and 12-well inserts and a deep well petri dish.

Reinnervate is also using its cell biology expertise to generate a library of synthetic small molecules that mediate stem cell differentiation in vitro. The first of these small molecules, Ec23^®, is commercially available and offers the potential for robust and reproducible differentiation of neural cell types.

Reinnervate was founded in 2002 based on the pioneering research of Professor Stefan Przyborski and his lab at Durham University, UK, and is funded by NorthStar Equity Investors (NSEI), management and private investors.

Alvetex^® was named as one of the top ten life science innovations of 2010 by The Scientist magazine.

www.reinnervate.com
www.reinnervate.com/company-video

About R&D Magazine

Since its founding in 1959 as Industrial Research, R&D Magazine has served research scientists, engineers and technical staff at laboratories around the world, providing timely, informative news and useful technical articles that broaden readers’ knowledge of the research and development industry and improve the quality of their work. R&D Magazine is a publication of Advantage Business Media.

www.advantagebusinessmedia.com.